Skip to main content

Table 6 Number of patients with dyspeptic symptoms at baseline and study end, stratified by baseline severity of symptoms (full analysis set)

From: Safety and efficacy of long-term esomeprazole 20 mg in Japanese patients with a history of peptic ulcer receiving daily non-steroidal anti-inflammatory drugs

Symptom

 

Baseline

 

Study end

None

Mild–Severe

Epigastric pain

None

100

18

Mild–Severe

8

4

Stomach discomfort

None

102

14

Mild–Severe

5

9

Abdominal fullness

None

100

18

Mild–Severe

4

8

Nausea/vomiting

None

116

8

 

Mild–Severe

4

2

Heartburn

None

112

14

 

Mild–Severe

3

1

Anorexia

None

111

10

 

Mild–Severe

7

2